RNU7-92P

Across TCGA pan-cancer cohorts, RNU7-92P RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated RNU7-92P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RNU7-92P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU7-92P expression acts as an unfavorable survival marker, although some lineages such as STAD show a favorable association.

KIRC, UCEC, and STAD are the cancer types where RNU7-92P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	II,III,IV	0.311	0.703	<.001	150	view →
UCEC	OS	Tertile	III,IV	0.471	0.836	.002	60	view →
STAD	OS	Tertile	II,III,IV	0.696	0.362	.023	36	view →
SKCM	DFS	Tertile	II,III,IV	0.210	0.685	.003	18	view →
SARC	DFS	Tertile	All	0.101	0.632	.011	18	view →
LGG	OS	Tertile	All	0.317	0.799	.015	9	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

RNU7-92P–KIRC (OS)

Open the KIRC breakdown →